Corteva, Inc. (NYSE:CTVA) Holdings Reduced by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. lowered its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 22.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 63,832 shares of the company's stock after selling 18,595 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in Corteva were worth $3,634,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Capital World Investors lifted its stake in shares of Corteva by 2,874.6% in the 4th quarter. Capital World Investors now owns 12,812,151 shares of the company's stock worth $729,780,000 after acquiring an additional 12,381,436 shares during the period. Independent Franchise Partners LLP lifted its position in Corteva by 51.5% in the fourth quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company's stock worth $939,641,000 after purchasing an additional 5,604,838 shares during the period. Norges Bank bought a new position in Corteva during the 4th quarter valued at $251,892,000. Raymond James Financial Inc. acquired a new position in shares of Corteva during the 4th quarter valued at $161,052,000. Finally, Franklin Resources Inc. raised its stake in shares of Corteva by 9.2% in the 4th quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company's stock worth $919,507,000 after buying an additional 1,354,418 shares in the last quarter. Institutional investors own 81.54% of the company's stock.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 26,560 shares of the company's stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the completion of the transaction, the insider now directly owns 11,347 shares in the company, valued at $723,257.78. The trade was a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.14% of the stock is owned by corporate insiders.

Corteva Stock Up 2.6 %

Corteva stock opened at $60.65 on Wednesday. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The firm has a market cap of $41.43 billion, a PE ratio of 47.02, a P/E/G ratio of 1.68 and a beta of 0.73. The firm's 50 day moving average price is $60.87 and its two-hundred day moving average price is $60.32.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, research analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date was Monday, March 3rd. Corteva's payout ratio is 52.71%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on CTVA shares. Royal Bank of Canada lifted their target price on Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. KeyCorp boosted their target price on shares of Corteva from $70.00 to $71.00 and gave the stock an "overweight" rating in a report on Monday, April 14th. Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 target price for the company in a report on Monday, March 31st. Wells Fargo & Company increased their price objective on Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a research report on Tuesday, January 28th. Finally, Barclays lifted their target price on Corteva from $62.00 to $64.00 and gave the stock an "equal weight" rating in a report on Tuesday, January 21st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $68.13.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.